Molecular Oncology
Volume 1, Issue 3 , Pages 246-251 , December 2007

The MINDACT trial: The first prospective clinical validation of a genomic tool

  • Fatima Cardoso

      Affiliations

    • Department of Medical Oncology, Institut Jules Bordet, Brussels, Belgium
    • Corresponding Author InformationCorresponding author. Tel.: +32 2 541 30 82; fax: +32 2 538 08 58.
    • ,
  • Martine Piccart-Gebhart

      Affiliations

    • Department of Medical Oncology, Institut Jules Bordet, Brussels, Belgium
    • ,
  • Laura Van’t Veer

      Affiliations

    • Department of Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands
    • ,
  • Emiel Rutgers

      Affiliations

    • Department of Surgery, The Netherlands Cancer Institute, Amsterdam, The Netherlands
    • ,
  • on behalf of the TRANSBIG consortium

Received 2 October 2007 ,Revised 11 October 2007 ,Accepted 17 October 2007.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S1574-7891(07)00077-4

doi: 10.1016/j.molonc.2007.10.004

Molecular Oncology
Volume 1, Issue 3 , Pages 246-251 , December 2007

Article Tools

* Image Usage & Resolution